Jeswinder Sian-Hulsmann,Peter Riederer
Jeswinder Sian-Hulsmann
Understanding cognitive features of cervical dystonia: application of the cerebellar cognitive affective syndrome scale (CCAS-S) [0.03%]
应用小脑认知情感综合征评分量表理解梅杰氏症患者神经认知特征的特点分析
Sara Terranova,Alessandro Botta,Martina Putzolu et al.
Sara Terranova et al.
Cervical Dystonia (CD) is now recognized to encompass a constellation of non-motor symptoms, including sensory, cognitive, and psychiatric manifestations, which significantly affect patients' quality of life. Cerebellar dysfunction may affe...
Association between nigrosome-1 appearance on MRI and fine motor function in healthy adults and people living with Parkinson's disease [0.03%]
健康成人和帕金森病患者中黑质区1在MRI上表现与精细运动功能的关系
Minh T Chau,Marc Agzarian,Robert A Wilcox et al.
Minh T Chau et al.
One proposed MRI biomarker for Parkinson's disease (PD) is the loss of hyperintense signal in nigrosome-1, a subregion of the dorsolateral substantia nigra pars compacta. However, little is known about the functional correlates of nigrosome...
Does preconditioning with serial casting prior to abobotulinumtoxinA injection improve outcomes in the rehabilitation of post-stroke wrist and finger flexor spasticity? [0.03%]
肉毒杆菌毒素注射前进行管状石膏预处理对中风后腕指屈肌痉挛康复的效果影响如何?
Peter Kossmehl,Katrin Naupold,Ricarda Temp et al.
Peter Kossmehl et al.
Post-stroke spasticity (PSS) affects up to 48% of stroke survivors, with disabling forms in about 18%. In the upper limb, 95% of cases show a flexor-dominant pattern. Botulinum toxin A (BoNT-A) is the treatment of choice, but adjunctive str...
Serum concentrations of selective serotonin reuptake inhibitors and atypical antipsychotics in children and adolescents: data from routine clinical care [0.03%]
选择性5-羟色胺再摄取抑制剂和非典型抗精神病药物的血药浓度:来自常规临床护理的数据
Sophie Wiegand,Xenia M Hart,Karin M Egberts et al.
Sophie Wiegand et al.
Therapeutic reference ranges (TRRs) for selective serotonin reuptake inhibitors (SSRIs) and atypical antipsychotics are established for adults. In children and adolescents, however, knowledge on TRRs of psychotropic drugs is scarce. The aim...
Polyneuropathy in Parkinson's disease and atypical Parkinsonian syndromes: clinical impact and risk factors [0.03%]
帕金森病和非典型帕金森综合征中的多发性神经病变:临床影响及危险因素分析
Amélie L Conring,Lan Ye,Florian Wegner et al.
Amélie L Conring et al.
Polyneuropathy (PNP) is increasingly recognized as a comorbidity in Parkinson's disease (PD) but its prevalence, clinical features and impact in atypical Parkinsonian syndromes (APS) remain unclear. Understanding PNP in Parkinsonism is cruc...
Cumulative hardship: the role of perceived injustice in linking war-related trauma and discrimination with mental health [0.03%]
累积的苦难:认知不公平在战争创伤和歧视与精神健康之间的联系中所起的作用
Christiane Wesarg-Menzel,Eileen Lashani,Mathilde Gallistl et al.
Christiane Wesarg-Menzel et al.
Exposure to war-related trauma and post-migration discrimination are significant risk factors for mental health problems among refugees and migrants. Understanding the mechanisms linking these experiences to psychological outcomes is essent...
Stress across systems and lifespan: emerging biomarkers and mechanisms of resilience [0.03%]
跨系统和生命周期的压力:韧性新兴的生物标志物和机制
Mustafa alAbsi
Mustafa alAbsi
Effects of levodopa-entacapone-carbidopa intrajejunal infusion on non-motor symptoms of advanced Parkinson's disease-interim analysis of the ELEGANCE study [0.03%]
左旋多巴-恩他卡朋-卡比多巴肠溶输注对帕金森病晚期非运动症状的影响:LUDIC研究的事后分析
Tobias Warnecke,Per Odin,Rocío García-Ramos et al.
Tobias Warnecke et al.
The ELEGANCE study (NCT05043103) is an ongoing, non-interventional registry study collecting real-world data on long-term efficacy, safety and patient-reported outcomes following treatment with levodopa-entacapone-carbidopa intestinal gel (...
Cross-sectional and longitudinal validation of short and long versions of the progressive supranuclear palsy quality of life scale [0.03%]
轴向和纵向验证进行帕金森症质粒生活评分的短版和长版
Qi Shen,Yi-Xin Zhao,Gan Tang et al.
Qi Shen et al.
Progressive supranuclear palsy (PSP) is an atypical parkinsonian disorder characterized by supranuclear gaze palsy, postural instability, parkinsonism, and frontal lobe disturbances. Severely impaired health-related quality of life (HRQoL) ...